Use of growth hormone in region 19p13.3 microduplication syndrome in girl with central early puberty: a clinical case report

• Autor(a) principal: Haber, Luiza Santos de Argollo
• Data de Publicação: 2021
• Outros Autores: Costanzo, Luiza Pedro, Turola, Ana Carolina de Magalhaes Leite, Araujo, Matheus Reverete de, Haber, Rafael Santos de Argollo, Mellem, Carolina Haber, Mellem, Rodrigo Haber, Chagas, Eduardo Federighi Baisi, Barbalho, Sandra Maria, Haber, Jesselina Francisco dos Santos
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: International Journal of Nutrology (Online)
• Texto Completo: https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/18
• topic: Chromosomal mutations; Chromosome 19p13.3; Growth hormone; Early puberty; Syndrome

Chromosomal mutations involving 19p13.3 have been described as pathogenic. clinical and phenotypic features can include, in most cases, psychomotor development delay, microcephaly, typical facial appearance, hand and foot anomalies, umbilical hernia, hypotonia, and low percentage of lean mass. The main types of mutation found on this chromosome are deletion or duplication. Short stature is often the cause of medical demand and the use of exogenous GH for patients with this syndrome is not beneficial. This article reports the case of a 5-year-old girl who sought medical help due to short stature and was diagnosed with this syndrome. Furthermore, this case study may contribute to the dissemination in the medical community about the association of this genetic mutation with the child's clinical condition, warning about this syndrome, and the possibility of the occurrence of early puberty. This study was analyzed and approved by the Research Ethics Committee (CEP) according to a substantiated opinion number 4.765.113.